secwatch / observer
8-K filed May 22, 2023, 7:59 PM ET ticker MRVI CIK 0001823239
other confidence high sentiment neutral materiality 0.10

Maravai LifeSciences shareholders elect three Class III directors at 2023 annual meeting

MARAVAI LIFESCIENCES HOLDINGS, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers at the 2023-05-18 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-05-18
Exact text from the filing
Proposal No. 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's Proxy Statement for the Annual Meeting. Votes For Votes Against Abstentions Broker Non-Votes 221,869,456 8,907,696 27,642 4,060,647
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Election of directors at the 2023-05-18 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-18
Exact text from the filing
Proposal No. 1: Election of directors. The Company’s shareholders elected the following nominees for director to serve as Class III directors for a three-year term expiring at the Company’s 2026 annual meeting of shareholders and until their successors are duly elected and qualified. Nominee Votes For Votes Withheld Broker Non-Votes Anat Ashkenazi 186,578,234 44,226,560 4,060,647 Gregory T. Lucier 186,046,648 44,758,145 4,060,648 Luke Marker 183,198,145 47,606,648 4,060,648
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-05-18 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-18
Exact text from the filing
Proposal No. 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 was ratified. Votes For Votes Against Abstentions 234,840,684 15,103 9,654
View on SEC.gov

546 shareholder votes filed in the last 30 days. Browse all shareholder votes →

MARAVAI LIFESCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001823239-23-000041
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.